During synthesis of IgG-like bispecific antibodies (bsAbs), product-related impurity formation via the mispairing of heavy chains and light chains (LCs) is common despite protein engineering efforts to mitigate these species. These mispaired impurities have similar biophysical characteristics to the target bsAb and are often difficult to remove with conventional platform processes. In this paper we demonstrate the utility of Capto MMC ImpRes for removing ½ IgG, homodimer and LC-mispair product-related impurities from an asymmetric IgG-like bsAb. Screening experiments from pH 5.0 to 9.5 showed that the ½ IgG and homodimer impurities eluted at pH 9.5, while the LC-mispair could be removed from the bsAb at pH 5.5 using a linear salt gradient. These results were then employed as a guide to propose a single column, multi-pH step gradient process for the removal of all product-related impurities. The final process included loading at pH 7.5 followed by elution of the homodimer and ½ IgG impurities from the column with a pH 9.5 wash. The column pH was then reduced to 5.5 and the LC-mispair impurity was subsequently removed during a 1 M NaCl step. Finally, a pH 8.0 with 1 M NaCl eluent was employed to recover the bound bsAb. This one step MMCEX polishing process resulted in an increased purity of the bsAb from 67.3% to 94.5% with a 72% overall recovery of the bsAb. These results demonstrate the utility of single column multimodal chromatographic processes when operated at multiple pHs for the removal of challenging product-related impurities from bsAbs.
Liquid chromatography-mass spectrometry (LC-MS) is an attractive alternative to GC-MS for oxysterol (OS) analysis, as it eliminates the need for chemical derivatization. However, in-source fragmentation during electrospray ionization (ESI) or atmospheric pressure chemical ionization (APCI), usually adopted for LC-MS analysis of OS, may lead to the generation of isomeric ions from non-isomeric precursors. This prevents a complete unambiguous identification along the MS dimension and makes chromatographic separation a fundamental step. In this work, analytical design space modelling empowered by a software-based modelling tool (DryLab®) was employed to optimize the reversed-phase LC separations of ten clinically relevant OS, including isomeric ring-oxidized and side chain-oxidized sterols. Three stationary phases, octadecyl (C18), cyanopropyl (ES-CN), and pentafluorophenyl (F5), were compared in terms of separation efficacy, using HPLC columns of identical geometry (150 × 2.1 mm, 2.7 μm) packed with core-shell particles. Gradient steepness, column temperature, and composition of the organic modifier (mixture of methanol and acetonitrile) in the mobile phase were selected as critical method parameters for successive construction of the design spaces on the selected stationary phases. All the resulting optimized methods resolved positional isomers and diastereomers, excepting 25(R/S)-26-hydroxycholesterol epimers. The C18 stationary phase (at 52 °C) offered high selectivity but demanded the longest run times (ca. 80 min). ES-CN (at 50 °C) and F5 (at 25 °C) stationary phases enabled faster effective runs (< 45 min), with ES-CN also reducing retention/chemical artifacts that are presumably triggered by π-π binding interactions with the stationary phase.

